|
|
||||||||





* Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104;
National Heart and Lung Institute, London, United Kingdom;
Centocor, Malvern, PA 19355;
Division of Neonatology, University of California, Davis, CA 95817;
¶
Division of Neonatology, University of California, San Francisco, CA 94143; and
||
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
The innate immune molecule surfactant protein-D (SP-D) plays an important regulatory role in the allergic airway response. In this study, we demonstrate that mice sensitized and challenged with either Aspergillus fumigatus (Af) or OVA have increased SP-D levels in their lung. SP-D mRNA and protein levels in the lung also increased in response to either rIL-4 or rIL-13 treatment. Type II alveolar epithelial cell expression of IL-4Rs in mice sensitized and challenged with Af, and in vitro induction of SP-D mRNA and protein by IL-4 and IL-13, but not IFN-
, suggested a direct role of IL-4R-mediated events. The regulatory function of IL-4 and IL-13 was further supported in STAT-6-deficient mice as well as in IL-4/IL-13 double knockout mice that failed to increase SP-D production upon allergen challenge. Interestingly, addition of rSP-D significantly inhibited Af-driven Th2 cell activation in vitro whereas mice lacking SP-D had increased numbers of CD4+ cells with elevated IL-13 and thymus- and activation-regulated chemokine levels in the lung and showed exaggerated production of IgE and IgG1 following allergic sensitization. We propose that allergen exposure induces elevation in SP-D protein levels in an IL-4/IL-13-dependent manner, which in turn, prevents further activation of sensitized T cells. This negative feedback regulatory circuit could be essential in protecting the airways from inflammatory damage after allergen inhalation.
This article has been cited by other articles:
![]() |
D. D. Sin, P. S. Pahlavan, and S.F. P. Man Review: Surfactant protein D: A lung specific biomarker in COPD? Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74. [Abstract] [PDF] |
||||
![]() |
R. Deb, F. Shakib, K. Reid, and H. Clark Major House Dust Mite Allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 Degrade and Inactivate Lung Surfactant Proteins A and D J. Biol. Chem., December 21, 2007; 282(51): 36808 - 36819. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hansen, B. Lo, K. Evans, P. Neophytou, U. Holmskov, and J. R. Wright Surfactant Protein D Augments Bacterial Association but Attenuates Major Histocompatibility Complex Class II Presentation of Bacterial Antigens Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 94 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wright The "wisdom" of lung surfactant: balancing host defense and surface tension-reducing functions Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L847 - L850. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |